An Equity-Based Strategy for COVID-19 Vaccine Distribution
Taking a broader, systems-level approach to the distribution of incoming COVID-19 vaccines may drive health equity.

The U.S. can and should cautiously assess the U.K.’s vaccination strategy to avoid challenges that may impede its ability to control the virus.

The EUA pathway may impede vital scientific progress needed to establish the long term safety and efficacy of investigational COVID-19 vaccines.
